DECIPHER
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Decipher Labs do?
Combat Drugs Ltd, a Public Limited Company established in 1986 in Secunderabad, Andhra Pradesh, specializes in the manufacture of Pharmaceutical Formulations, contributing significantly to the development of the pharmaceutical industry.
Who are the competitors of Decipher Labs?
Decipher Labs major competitors are Unjha Formulations, Cian Healthcare, Venmax Drugs&Pharma, iStreet Network, Beryl Drugs, Hind Bio Science, Shamrock Indl. Co. Market Cap of Decipher Labs is ₹11 Crs. While the median market cap of its peers are ₹10 Crs.
Is Decipher Labs financially stable compared to its competitors?
Decipher Labs seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Decipher Labs pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Decipher Labs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Decipher Labs allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Decipher Labs balance sheet?
Balance sheet of Decipher Labs is moderately strong.
Is the profitablity of Decipher Labs improving?
The profit is oscillating. The profit of Decipher Labs is -₹5.08 Crs for TTM, -₹1.68 Crs for Mar 2024 and -₹2.68 Crs for Mar 2023.
Is the debt of Decipher Labs increasing or decreasing?
Yes, The net debt of Decipher Labs is increasing. Latest net debt of Decipher Labs is -₹2.56 Crs as of Mar-25. This is greater than Mar-24 when it was -₹18.63 Crs.
Is Decipher Labs stock expensive?
Decipher Labs is not expensive. Latest PE of Decipher Labs is 0.0, while 3 year average PE is 17.14. Also latest EV/EBITDA of Decipher Labs is 0.0 while 3yr average is 7.14.
Has the share price of Decipher Labs grown faster than its competition?
Decipher Labs has given lower returns compared to its competitors. Decipher Labs has grown at ~-39.48% over the last 3yrs while peers have grown at a median rate of 35.52%
Is the promoter bullish about Decipher Labs?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Decipher Labs is 16.43% and last quarter promoter holding is 16.43%.
Are mutual funds buying/selling Decipher Labs?
There is Insufficient data to gauge this.